Celldex Therapeutics, Inc. (CLDX) on GreekSoup https://greeksoup.ai/stocks/us/cldx/ Every dated entry in the public record on Celldex Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Celldex Therapeutics, Inc.: short interest 9,598,891 shares at the 15 October 2026 settlement, 5.88 days to coverhttps://greeksoup.ai/stocks/us/cldx/short-interest/us:CLDX:short-interest:2026-10-15:a4c73ecd57Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: Schedule 13G/A filed by FMR LLC, 10.7% of the classhttps://greeksoup.ai/stocks/us/cldx/holders/us:CLDX:schedule-13:2026-10-07:1f5b716f36Wed, 07 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: short interest 11,006,720 shares at the 30 September 2026 settlement, 3.81 days to coverhttps://greeksoup.ai/stocks/us/cldx/short-interest/us:CLDX:short-interest:2026-09-30:ad2f13b744Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/cldx/filings/us:CLDX:filing:2026-09-22:2381a9885cTue, 22 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: short interest 8,953,127 shares at the 15 September 2026 settlement, 13.12 days to coverhttps://greeksoup.ai/stocks/us/cldx/short-interest/us:CLDX:short-interest:2026-09-15:11066d0f06Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: short interest 8,641,597 shares at the 31 August 2026 settlement, 12.23 days to coverhttps://greeksoup.ai/stocks/us/cldx/short-interest/us:CLDX:short-interest:2026-08-31:f4bcbc8112Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: Schedule 13G/A filed by Kynam Capital Management, LP, 6.8% of the classhttps://greeksoup.ai/stocks/us/cldx/holders/us:CLDX:schedule-13:2026-08-14:adf50c6b81Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: Schedule 13G filed by T. Rowe Price Associates, Inc., 6.0% of the classhttps://greeksoup.ai/stocks/us/cldx/holders/us:CLDX:schedule-13:2026-08-14:cf97cbf181Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: short interest 7,569,702 shares at the 14 August 2026 settlement, 7.93 days to coverhttps://greeksoup.ai/stocks/us/cldx/short-interest/us:CLDX:short-interest:2026-08-14:8d0356939aFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc. Q2 FY2026 results: revenue $22,000, net income -$74 millionhttps://greeksoup.ai/stocks/us/cldx/results/fy2026-q2/us:CLDX:result:2026-08-06:098325863aThu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/cldx/filings/us:CLDX:filing:2026-08-06:4d729f6a06Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/cldx/filings/us:CLDX:filing:2026-08-06:02affcde5aThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Celldex Therapeutics, Inc.: short interest 7,627,081 shares at the 31 July 2026 settlement, 7.62 days to coverhttps://greeksoup.ai/stocks/us/cldx/short-interest/us:CLDX:short-interest:2026-07-31:9c8c44a747Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>